ASCO Scientific Program 2010: Provectus Pharmaceuticals’ Phase 2 data on PV-10 accepted for presentation Provectus Pharmaceuticals, Inc. Sanjiv Agarwala, Chief, Medical Hematology and Oncology at St suhagrastore.com . Dr. As I noted recently, PV-10 is intriguing if you ask me as an oncologist because it appears to recruit immune cells to the ablation site, leading to the potential of a systemic benefit. Metastatic melanoma is certainly a deadly and dreadful disease, and we believe PV-10 holds promise mainly because a viable, safe and effective treatment, with minimal side effects, not only because of this disease, but potentially for a wide spectrum of other cancers as well.
The otolaryngology – head and neck medical procedures societies participating in the combined achieving are the American Society of Pediatric Otolaryngology, American Broncho-Esophagological Association, American Head and Throat Society, American Laryngological Association, American Neurotology Society, American Otological Society, American Rhinologic Society, and the Triological Culture.. ASPO meeting to focus on children’s ear, throat and nose health Nation’s pediatric otolaryngologists to convene in Las Vegas, April 30-May 2The American Culture of Pediatric Otolaryngology will hold its annual meeting, April 30 – May 2, through the 2010 Combined Otolaryngology Spring Meetings – a joint meeting of eight otolaryngological societies in NEVADA, NV. During the ASPO meeting, hundreds of pieces of new analysis and dozens of scientific sessions featuring expert panelists will be presented focusing on children’s ear, nose, and throat wellness.